Detalhe da pesquisa
1.
Phase 2 prospective open label study of neoadjuvant nab-paclitaxel, trastuzumab, and pertuzumab in patients with HER2-positive primary breast cancer.
Cancer
; 129(5): 740-749, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36517940
2.
Phase I Trial of Ipatasertib Plus Carboplatin, Carboplatin/Paclitaxel, or Capecitabine and Atezolizumab in Metastatic Triple-Negative Breast Cancer.
Oncologist
; 28(7): e498-e507, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37023705
3.
Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer.
Cancer Immunol Immunother
; 72(9): 3013-3027, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37294342
4.
Fusariosis in Mexico: A 10-year retrospective series.
Med Mycol
; 61(12)2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37944000
5.
A Phase II Clinical Trial of Pembrolizumab and Enobosarm in Patients with Androgen Receptor-Positive Metastatic Triple-Negative Breast Cancer.
Oncologist
; 26(2): 99-e217, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33141975
6.
Phase II Trial of Neoadjuvant Carboplatin and Nab-Paclitaxel in Patients with Triple-Negative Breast Cancer.
Oncologist
; 26(3): e382-e393, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33098195
7.
Metronidazole and Secnidazole Carbamates: Synthesis, Antiprotozoal Activity, and Molecular Dynamics Studies.
Molecules
; 25(4)2020 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32059495
8.
Phase I clinical trial of the combination of eribulin and everolimus in patients with metastatic triple-negative breast cancer.
Breast Cancer Res
; 21(1): 119, 2019 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31703728
9.
Influenza A (H1N1pdm09)-Related Critical Illness and Mortality in Mexico and Canada, 2014.
Crit Care Med
; 44(10): 1861-70, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27359085
10.
Arbovirus Surveillance and First Report of Chikungunya Virus in Wild Populations of Aedes aegypti from Guerrero, Mexico.
J Am Mosq Control Assoc
; 31(3): 275-7, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26375910
11.
Multiple human papillomavirus infections are highly prevalent in the anal canal of human immunodeficiency virus-positive men who have sex with men.
BMC Infect Dis
; 14: 671, 2014 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-25510243
12.
Natural vertical transmission of dengue-1 virus in Aedes aegypti populations in Acapulco, Mexico.
J Am Mosq Control Assoc
; 30(2): 143-6, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25102601
13.
CF33-hNIS-anti-PD-L1 oncolytic virus followed by trastuzumab-deruxtecan in a patient with metastatic triple negative breast cancer: a case study.
Ther Adv Med Oncol
; 15: 17588359231210675, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38028143
14.
Evaluation of the Antioxidant and Antimicrobial Potential of SiO2 Modified with Cinnamon Essential Oil (Cinnamomum Verum) for Its Use as a Nanofiller in Active Packaging PLA Films.
Antioxidants (Basel)
; 12(5)2023 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37237956
15.
SARS-CoV-2 Vaccine Effectiveness in Hospitalized Patients: A Multicenter Test-Negative Case-Control Study.
Vaccines (Basel)
; 11(12)2023 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38140183
16.
In vitro activities of the new antitubercular agents PA-824 and BTZ043 against Nocardia brasiliensis.
Antimicrob Agents Chemother
; 56(7): 3984-5, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22526312
17.
Phase II Study Combining Pembrolizumab with Aromatase Inhibitor in Patients with Metastatic Hormone Receptor Positive Breast Cancer.
Cancers (Basel)
; 14(17)2022 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36077811
18.
Preclinical Assessment of IgY Antibodies Against Recombinant SARS-CoV-2 RBD Protein for Prophylaxis and Post-Infection Treatment of COVID-19.
Front Immunol
; 13: 881604, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35664008
19.
Squalene in oil-based adjuvant improves the immunogenicity of SARS-CoV-2 RBD and confirms safety in animal models.
PLoS One
; 17(8): e0269823, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35998134
20.
A Randomized Clinical Trial of Regdanvimab in High-Risk Patients With Mild-to-Moderate Coronavirus Disease 2019.
Open Forum Infect Dis
; 9(8): ofac406, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36043180